Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.

To test the anti-tumour activity of rhizoxin in recurrent and/or metastatic squamous cell head and neck cancer, we performed a phase II study. Eligibility required histologically proven squamous cell head and neck cancer. Patients could only have received one prior chemotherapy. Patients were entere...

Descripción completa

Detalles Bibliográficos
Autores principales: Verweij, J., Wanders, J., Gil, T., Schöffski, P., Catimel, G., te Velde, A., de Mulder, P. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074424/
https://www.ncbi.nlm.nih.gov/pubmed/8562350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074424/
https://www.ncbi.nlm.nih.gov/pubmed/8562350

Ejemplares similares